Literature DB >> 10861514

Human NT2 neurons express a large variety of neurotransmission phenotypes in vitro.

I Guillemain1, G Alonso, G Patey, A Privat, I Chaudieu.   

Abstract

The NT2 cell line, which was derived from a human teratocarcinoma, exhibits properties that are characteristic of a committed neuronal precursor at an early stage of development. NT2 cells can be induced by retinoic acid to differentiate in vitro into postmitotic central nervous system (CNS) neurons (NT2-N cells). The commitment of NT2-N cells to a stable neuronal phenotype is irreversible. Because it may be possible to transplant these human neurons to compensate for neuronal loss after traumatic injuries or neurodegenerative diseases of the CNS, knowledge of their phenotype is essential. This study aimed to characterize in detail the neurotransmission phenotype of NT2-N cells by using immunocytochemical methods. Single peroxidase immunostaining demonstrated that NT2-N cells expressed the gamma-aminobutyric acidergic (GABAergic), catecholaminergic, and cholinergic phenotypes to a large extent and expressed the serotonergic phenotype to a minor extent. NT2-N cells also expressed different neuropeptides, such as neuropeptide Y, oxytocin, vasopressin, calcitonin gene-related peptide, and Met- and Leu-enkephalin. Double fluorescence immunostaining further indicated that a large number of NT2-N cells could express GABA and another neurotransmitter or neuropeptide at the same time. Finally, electron microscopy demonstrated that these NT2 neurons elaborate classical synaptic contacts. The multipotentiality of these neurons, combined with their apparent functionality, suggests that they may represent useful material for a variety of therapeutic approaches aimed at replacing dead neurons after neurodegenerative diseases or lesions of the CNS. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861514     DOI: 10.1002/1096-9861(20000703)422:3<380::aid-cne5>3.0.co;2-c

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  23 in total

1.  Neurotransmitter vesicle release from human model neurons (NT2) is sensitive to botulinum toxin A.

Authors:  Million Adane Tegenge; Helge Böhnel; Frank Gessler; Gerd Bicker
Journal:  Cell Mol Neurobiol       Date:  2012-02-29       Impact factor: 5.046

Review 2.  Cell therapy for stroke.

Authors:  Sean I Savitz; Jonathan H Dinsmore; Lawrence R Wechsler; Daniel M Rosenbaum; Louis R Caplan
Journal:  NeuroRx       Date:  2004-10

3.  IL-29/IL-28A suppress HSV-1 infection of human NT2-N neurons.

Authors:  Lin Zhou; Jieliang Li; Xu Wang; Li Ye; Wei Hou; Jie Ho; He Li; Wenzhe Ho
Journal:  J Neurovirol       Date:  2011-04-16       Impact factor: 2.643

4.  Tumor-associated antigen expression and growth requirements predict tumorigenesis in squamous cell carcinoma.

Authors:  E R Salter; D Tichansky; E E Furth; A M Herlyn
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

5.  Evaluation of the importance of astrocytes when screening for acute toxicity in neuronal cell systems.

Authors:  E K Woehrling; E J Hill; M D Coleman
Journal:  Neurotox Res       Date:  2009-07-11       Impact factor: 3.911

6.  Morphine suppresses intracellular interferon-alpha expression in neuronal cells.

Authors:  Qi Wan; Xu Wang; Yan-Jian Wang; Li Song; Shi-Hong Wang; Wen-Zhe Ho
Journal:  J Neuroimmunol       Date:  2008-06-17       Impact factor: 3.478

7.  Human neuronal cells (NT2-N) express functional substance P and neurokinin-1 receptor coupled to MIP-1 beta expression.

Authors:  Yuan Li; Steven D Douglas; David E Pleasure; Jianping Lai; Changjiang Guo; Peter Bannerman; Marge Williams; Wenzhe Ho
Journal:  J Neurosci Res       Date:  2003-02-15       Impact factor: 4.164

Review 8.  Stem cells: implications in experimental ischaemic stroke therapy.

Authors:  Ashish K Rehni; Inderbir Singh; Nirmal Singh; Manoj Kumar
Journal:  Stem Cell Rev       Date:  2008-05-31       Impact factor: 5.739

9.  Novel cellular approaches to repair of neurodegenerative disease: from Sertoli cells to umbilical cord blood stem cells.

Authors:  Paul R Sanberg; Alison E Willing; David W Cahill
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

10.  Preliminary study of the behavioral effects of LBS-neuron implantation on seizure susceptibility following middle cerebral artery occlusion in the rats.

Authors:  Alison E Willing; Samuel Saporta; Jiang Lixian; Melissa Milliken; Steve Poulos; Scott S Bowersox; Paul R Sanberg
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.